The Research and Development team at Prelude Therapeutics focuses on discovering and developing innovative drug candidates targeting critical cancer cell pathways. Comprising scientists and researchers across various specializations—including biology, biochemistry, medicinal chemistry, and informatics—the team conducts cutting-edge research to identify new therapeutic targets, optimize lead compounds, and advance promising candidates through preclinical and clinical development stages. Their collaborative efforts aim to bring transformative cancer treatments from the lab to the clinic.
View all